OPEN END TURBO LONG - STRYKER CORP. Stock

Certificat

DE000MD6A2S5

Market Closed - Bid/Ask 11:01:26 2024-07-04 am EDT After market 02:35:23 pm
10.79 EUR +1.60% Intraday chart for OPEN END TURBO LONG - STRYKER CORP. 10.92 +1.25%
Current month-7.01%
1 month-6.84%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-04 10.79 +1.60%
24-07-03 10.62 -2.39%
24-07-02 10.88 -1.81%
24-07-01 11.08 -2.98%
24-06-28 11.42 -0.78%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 11:01 am EDT

More quotes

Static data

Product typeWarrant Knock-Out senza Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MD6A2S
ISINDE000MD6A2S5
Date issued 2022-07-14
Strike 217.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.64
Lowest since issue 0.47
Spread 0.25
Spread %2.26%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
332 USD
Average target price
372.7 USD
Spread / Average Target
+12.27%
Consensus